ADX-626
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ADX-626, covering 2026-03-02 to 2026-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of ADX-626 in Healthy Participants [Phase 1]